
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CNS Pharmaceuticals (NASDAQ:CNSP) through any online brokerage.
Other companies in CNS Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
CNS Pharmaceuticals has a consensus price target of $20.00.
The stock price for CNS Pharmaceuticals (NASDAQ: CNSP) is $5 last updated October 8, 2026 at 6:58 AM EDT.
There are no upcoming dividends for CNS Pharmaceuticals.
CNS Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for CNS Pharmaceuticals.
CNS Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes...